Advita Ortho announced today it has obtained three novel intellectual property applications from Bauer Innovations that expand Advita’s growing Equinoxe® Shoulder System portfolio, extending its capabilities to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA).
These unique technologies will facilitate new advances in reverse shoulder arthroplasty implant design. Advita intends to implement these patents to design new reverse shoulder glenoid baseplates that better support orthopedic surgeons when performing revision shoulder arthroplasty by improving glenoid fixation in patients with central vault defects and uncontained glenoid defects.
“This important acquisition will help expand Advita’s portfolio of innovative Equinoxe Shoulder System solutions, allowing us to develop a next-generation rTSA glenoid revision baseplate system that enables surgeons to treat their most difficult glenoid bone loss patients in a more efficient manner,” said Chris Roche, Advita’s Senior Vice President of Extremities. “This investment facilitates development of a revision rTSA glenoid baseplate that will be able to address practically any size or shape glenoid defect, using an off-the-shelf component.”
...My experience during these procedures inspired the development of the intellectual property; I felt we needed something between standard implants with bone grafts and custom implants....
“Bauer Innovations and I share Advita’s vision for a comprehensive solution for glenoid defects encountered during revision surgery,” said Greg Bauer, MD, of Bauer Innovations. “My experience during these procedures inspired the development of the intellectual property; I felt we needed something between standard implants with bone grafts and custom implants. I am proud of what Bauer Innovations developed, and we are excited to continue that work with Advita and utilize this intellectual property to commercialize a novel revision glenoid system that will help surgeons treat their most challenging patients with glenoid bone loss.”
The acquisition further solidifies Advita’s portfolio of shoulder technologies as the company continues investing in solutions that combine innovative implant design with intelligent technologies.
